speb/financial-data huggingface dataset:
MED.SW income_statement (annual, 2022-12-31) — EBIT: -6411000.00
MED.SW income_statement (annual, 2022-12-31) — EBITDA: 11701000.00
MED.SW cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -1300000.00
MED.SW cash_flow (annual, 2022-12-31) — End Cash Position: 20605000.00
MED.SW cash_flow (annual, 2022-12-31) — Financing Cash Flow: -3899000.00
MED.SW balance_sheet (annual, 2022-12-31) — Finished Goods: 24213000.00
MED.SW cash_flow (annual, 2022-12-31) — Free Cash Flow: -22719000.00
MED.SW cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 235000.00
MED.SW income_statement (annual, 2022-12-31) — General And Administrative Expense: 31692000.00
MED.SW balance_sheet (annual, 2022-12-31) — Goodwill: 38549000.00
MED.SW balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 69991000.00
MED.SW balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 41140000.00
MED.SW balance_sheet (annual, 2022-12-31) — Gross PPE: 158718000.00
MED.SW income_statement (annual, 2022-12-31) — Gross Profit: 149489000.00
MED.SW income_statement (annual, 2022-12-31) — Interest Expense: 734000.00
MED.SW income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 734000.00
MED.SW income_statement (annual, 2022-12-31) — Interest Income: 250000.00
MED.SW income_statement (annual, 2022-12-31) — Interest Income Non Operating: 250000.00
MED.SW cash_flow (annual, 2022-12-31) — Interest Paid Cff: -734000.00
MED.SW cash_flow (annual, 2022-12-31) — Interest Received Cfo: 300000.00
MED.SW balance_sheet (annual, 2022-12-31) — Inventory: 69903000.00
MED.SW balance_sheet (annual, 2022-12-31) — Invested Capital: 238242000.00
MED.SW cash_flow (annual, 2022-12-31) — Investing Cash Flow: -52913000.00
MED.SW balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 1557000.00
MED.SW balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 13873000.00
MED.SW cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 1882000.00
MED.SW balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 21872000.00
MED.SW balance_sheet (annual, 2022-12-31) — Long Term Debt: 463000.00
MED.SW balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 22335000.00
MED.SW balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 13873000.00
MED.SW balance_sheet (annual, 2022-12-31) — Long Term Provisions: 2260000.00
MED.SW balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 53560000.00
MED.SW cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -39811000.00
MED.SW cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 1882000.00
MED.SW income_statement (annual, 2022-12-31) — Net Income: -5783000.00
MED.SW income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -5783000.00
MED.SW income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -5783000.00
MED.SW income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -5783000.00
MED.SW income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -5783000.00
MED.SW cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -5783000.00
MED.SW income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -5783000.00
MED.SW cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -3359000.00
MED.SW income_statement (annual, 2022-12-31) — Net Interest Income: -2035000.00
MED.SW cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 5480000.00
MED.SW cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
MED.SW income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2035000.00
MED.SW cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1000.00
MED.SW cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 1000.00
MED.SW balance_sheet (annual, 2022-12-31) — Net PPE: 79284000.00
MED.SW cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -15224000.00
MED.SW cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
MED.SW balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 167788000.00
MED.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 25308000.00
MED.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 107000.00
MED.SW balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1804000.00
MED.SW income_statement (annual, 2022-12-31) — Normalized EBITDA: 11701000.00
MED.SW income_statement (annual, 2022-12-31) — Normalized Income: -5783000.00
MED.SW cash_flow (annual, 2022-12-31) — Operating Cash Flow: -3925000.00
MED.SW income_statement (annual, 2022-12-31) — Operating Income: -1870000.00
MED.SW income_statement (annual, 2022-12-31) — Operating Revenue: 182824000.00
MED.SW balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 11856569.00
MED.SW cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: 1.00
MED.SW balance_sheet (annual, 2022-12-31) — Other Current Assets: 2.00
MED.SW balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 686000.00
MED.SW balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 31442000.00
MED.SW balance_sheet (annual, 2022-12-31) — Other Inventories: 27489000.00
MED.SW cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2929000.00
MED.SW balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 24083000.00
MED.SW balance_sheet (annual, 2022-12-31) — Other Payable: 8691000.00
MED.SW balance_sheet (annual, 2022-12-31) — Other Properties: 50243000.00
MED.SW balance_sheet (annual, 2022-12-31) — Other Receivables: 4877000.00
MED.SW income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
MED.SW balance_sheet (annual, 2022-12-31) — Payables: 19876000.00
MED.SW cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: -436000.00
MED.SW balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3415000.00
MED.SW balance_sheet (annual, 2022-12-31) — Prepaid Assets: 2405000.00
MED.SW income_statement (annual, 2022-12-31) — Pretax Income: -7145000.00
MED.SW balance_sheet (annual, 2022-12-31) — Properties: 0.00
MED.SW cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: -436000.00
MED.SW cash_flow (annual, 2022-12-31) — Purchase Of Business: -39811000.00
MED.SW cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -3359000.00
MED.SW cash_flow (annual, 2022-12-31) — Purchase Of PPE: -15435000.00
MED.SW balance_sheet (annual, 2022-12-31) — Raw Materials: 1019000.00
MED.SW income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 33335000.00
MED.SW income_statement (annual, 2022-12-31) — Reconciled Depreciation: 18112000.00
MED.SW cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
MED.SW income_statement (annual, 2022-12-31) — Research And Development: 25332000.00
MED.SW balance_sheet (annual, 2022-12-31) — Retained Earnings: -23051000.00
MED.SW cash_flow (annual, 2022-12-31) — Sale Of PPE: 211000.00
MED.SW income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 94335000.00
MED.SW income_statement (annual, 2022-12-31) — Selling General And Administration: 126027000.00
MED.SW balance_sheet (annual, 2022-12-31) — Share Issued: 11856569.00
MED.SW cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
MED.SW cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2197000.00
MED.SW balance_sheet (annual, 2022-12-31) — Stockholders Equity: 237779000.00
MED.SW balance_sheet (annual, 2022-12-31) — Tangible Book Value: 167788000.00
MED.SW income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
MED.SW income_statement (annual, 2022-12-31) — Tax Provision: -1362000.00
MED.SW income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.19
MED.SW balance_sheet (annual, 2022-12-31) — Taxes Receivable: 160000.00
MED.SW cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -838000.00
MED.SW balance_sheet (annual, 2022-12-31) — Total Assets: 327894000.00
MED.SW balance_sheet (annual, 2022-12-31) — Total Capitalization: 238242000.00
MED.SW balance_sheet (annual, 2022-12-31) — Total Debt: 27493000.00
MED.SW balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 237779000.00
MED.SW income_statement (annual, 2022-12-31) — Total Expenses: 184694000.00
MED.SW balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 90115000.00
MED.SW balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 190013000.00
MED.SW balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 50589000.00
MED.SW income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -1922000.00
MED.SW income_statement (annual, 2022-12-31) — Total Other Finance Cost: 1551000.00
MED.SW balance_sheet (annual, 2022-12-31) — Total Tax Payable: 1590000.00
MED.SW balance_sheet (annual, 2022-12-31) — Work In Process: 17182000.00
MED.SW balance_sheet (annual, 2022-12-31) — Working Capital: 98355000.00
MED.SW income_statement (annual, 2023-12-31) — +Operating Expense: 159252000.00
MED.SW income_statement (annual, 2023-12-31) — +Total Revenue: 212006000.00
MED.SW balance_sheet (annual, 2023-12-31) — Accounts Payable: 8240000.00
MED.SW balance_sheet (annual, 2023-12-31) — Accounts Receivable: 40476000.00
MED.SW balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -87226000.00
MED.SW balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -3514000.00
MED.SW cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 4094000.00
MED.SW balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 998000.00
MED.SW income_statement (annual, 2023-12-31) — Basic Average Shares: 12231883.00
MED.SW income_statement (annual, 2023-12-31) — Basic EPS: 0.05
MED.SW cash_flow (annual, 2023-12-31) — Beginning Cash Position: 20605000.00
MED.SW balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 56116000.00
MED.SW cash_flow (annual, 2023-12-31) — Capital Expenditure: -18808000.00
MED.SW balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 26924000.00
MED.SW balance_sheet (annual, 2023-12-31) — Capital Stock: 2472000.00
MED.SW balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 25201000.00
MED.SW balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 25201000.00
MED.SW cash_flow (annual, 2023-12-31) — Change In Inventory: 1602000.00
MED.SW cash_flow (annual, 2023-12-31) — Change In Payable: 1283000.00
MED.SW cash_flow (annual, 2023-12-31) — Change In Receivables: -265000.00
MED.SW cash_flow (annual, 2023-12-31) — Change In Working Capital: 2620000.00
MED.SW cash_flow (annual, 2023-12-31) — Changes In Cash: 5345000.00
MED.SW balance_sheet (annual, 2023-12-31) — Common Stock: 2472000.00
MED.SW balance_sheet (annual, 2023-12-31) — Common Stock Equity: 254959000.00
MED.SW cash_flow (annual, 2023-12-31) — Common Stock Issuance: 29788000.00
MED.SW income_statement (annual, 2023-12-31) — Cost Of Revenue: 44434000.00
MED.SW balance_sheet (annual, 2023-12-31) — Current Assets: 141419000.00
MED.SW balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 6297000.00
MED.SW balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 6297000.00
MED.SW balance_sheet (annual, 2023-12-31) — Current Liabilities: 45956000.00
MED.SW balance_sheet (annual, 2023-12-31) — Current Provisions: 1573000.00
MED.SW cash_flow (annual, 2023-12-31) — Deferred Tax: 1174000.00
MED.SW cash_flow (annual, 2023-12-31) — Depreciation: 18667000.00
MED.SW cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 22761000.00
MED.SW income_statement (annual, 2023-12-31) — Diluted Average Shares: 12270584.00
MED.SW income_statement (annual, 2023-12-31) — Diluted EPS: 0.05
MED.SW income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 619000.00
MED.SW income_statement (annual, 2023-12-31) — EBIT: 2622000.00
MED.SW income_statement (annual, 2023-12-31) — EBITDA: 25383000.00
MED.SW cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -749000.00
MED.SW cash_flow (annual, 2023-12-31) — End Cash Position: 25201000.00
MED.SW cash_flow (annual, 2023-12-31) — Financing Cash Flow: 23197000.00
MED.SW balance_sheet (annual, 2023-12-31) — Finished Goods: 20225000.00
MED.SW cash_flow (annual, 2023-12-31) — Free Cash Flow: 1172000.00
MED.SW cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 412000.00
MED.SW income_statement (annual, 2023-12-31) — General And Administrative Expense: 34480000.00
MED.SW balance_sheet (annual, 2023-12-31) — Goodwill: 35279000.00
MED.SW balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 64653000.00
MED.SW balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 43990000.00
MED.SW balance_sheet (annual, 2023-12-31) — Gross PPE: 167294000.00
MED.SW income_statement (annual, 2023-12-31) — Gross Profit: 167572000.00
MED.SW income_statement (annual, 2023-12-31) — Interest Expense: 828000.00
MED.SW income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 828000.00
MED.SW income_statement (annual, 2023-12-31) — Interest Income: 337000.00
MED.SW income_statement (annual, 2023-12-31) — Interest Income Non Operating: 337000.00
MED.SW cash_flow (annual, 2023-12-31) — Interest Paid Cff: -828000.00
MED.SW cash_flow (annual, 2023-12-31) — Interest Received Cfo: 337000.00
MED.SW balance_sheet (annual, 2023-12-31) — Inventory: 68301000.00
MED.SW balance_sheet (annual, 2023-12-31) — Invested Capital: 254959000.00
MED.SW cash_flow (annual, 2023-12-31) — Investing Cash Flow: -37832000.00
MED.SW balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 998000.00
MED.SW balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 33259000.00
MED.SW cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 29788000.00
MED.SW balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 20627000.00
MED.SW balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 20627000.00
MED.SW balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 33259000.00
MED.SW balance_sheet (annual, 2023-12-31) — Long Term Provisions: 2609000.00
MED.SW balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 56414000.00
MED.SW cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -19615000.00
MED.SW cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 29788000.00
MED.SW income_statement (annual, 2023-12-31) — Net Income: 619000.00
MED.SW income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 619000.00
MED.SW income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 620000.00
MED.SW income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 619000.00
MED.SW income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 619000.00
MED.SW cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 619000.00
MED.SW income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 619000.00
MED.SW cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -3874000.00
MED.SW income_statement (annual, 2023-12-31) — Net Interest Income: -1399000.00
MED.SW cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 559000.00
MED.SW cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -463000.00
MED.SW income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1399000.00
MED.SW balance_sheet (annual, 2023-12-31) — Net PPE: 80068000.00
MED.SW cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -14902000.00
MED.SW cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -463000.00
MED.SW balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 190306000.00
MED.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 29138000.00
MED.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 200000.00
MED.SW balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 10403000.00
MED.SW income_statement (annual, 2023-12-31) — Normalized EBITDA: 25383000.00
MED.SW income_statement (annual, 2023-12-31) — Normalized Income: 619000.00
MED.SW cash_flow (annual, 2023-12-31) — Operating Cash Flow: 19980000.00
MED.SW income_statement (annual, 2023-12-31) — Operating Income: 8320000.00
MED.SW income_statement (annual, 2023-12-31) — Operating Revenue: 212006000.00
MED.SW balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 12359185.00
MED.SW balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 9072000.00
MED.SW balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 29374000.00
MED.SW balance_sheet (annual, 2023-12-31) — Other Inventories: 31965000.00
MED.SW cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1410000.00
MED.SW balance_sheet (annual, 2023-12-31) — Other Non Current Assets: -1000.00
MED.SW balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 14780000.00
MED.SW income_statement (annual, 2023-12-31) — Other Operating Expenses: 1357000.00
MED.SW balance_sheet (annual, 2023-12-31) — Other Payable: 9158000.00
MED.SW balance_sheet (annual, 2023-12-31) — Other Properties: 54764000.00
MED.SW balance_sheet (annual, 2023-12-31) — Other Receivables: 5664000.00
MED.SW income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
MED.SW balance_sheet (annual, 2023-12-31) — Payables: 20300000.00
MED.SW cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: -5402000.00
MED.SW balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3692000.00
MED.SW balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1338000.00
MED.SW income_statement (annual, 2023-12-31) — Pretax Income: 1794000.00
MED.SW balance_sheet (annual, 2023-12-31) — Properties: 0.00
MED.SW cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -5402000.00
MED.SW cash_flow (annual, 2023-12-31) — Purchase Of Business: -19615000.00
MED.SW cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -3874000.00
MED.SW cash_flow (annual, 2023-12-31) — Purchase Of PPE: -14934000.00
MED.SW balance_sheet (annual, 2023-12-31) — Raw Materials: 911000.00
MED.SW income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 44434000.00
MED.SW income_statement (annual, 2023-12-31) — Reconciled Depreciation: 22761000.00
MED.SW cash_flow (annual, 2023-12-31) — Repayment Of Debt: -463000.00
MED.SW income_statement (annual, 2023-12-31) — Research And Development: 25906000.00
MED.SW balance_sheet (annual, 2023-12-31) — Retained Earnings: -30841000.00
MED.SW cash_flow (annual, 2023-12-31) — Sale Of PPE: 32000.00
MED.SW income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 97509000.00
MED.SW income_statement (annual, 2023-12-31) — Selling General And Administration: 131989000.00
MED.SW balance_sheet (annual, 2023-12-31) — Share Issued: 12359185.00
MED.SW cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -463000.00
MED.SW cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1236000.00
MED.SW balance_sheet (annual, 2023-12-31) — Stockholders Equity: 254959000.00
MED.SW balance_sheet (annual, 2023-12-31) — Tangible Book Value: 190306000.00
MED.SW income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
MED.SW income_statement (annual, 2023-12-31) — Tax Provision: 1174000.00
MED.SW income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.09
MED.SW balance_sheet (annual, 2023-12-31) — Taxes Receivable: 439000.00
MED.SW cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -5188000.00
MED.SW balance_sheet (annual, 2023-12-31) — Total Assets: 349534000.00
MED.SW balance_sheet (annual, 2023-12-31) — Total Capitalization: 254959000.00
MED.SW balance_sheet (annual, 2023-12-31) — Total Debt: 26924000.00
MED.SW balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 254959000.00
MED.SW income_statement (annual, 2023-12-31) — Total Expenses: 203686000.00
MED.SW balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 94575000.00
MED.SW balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 208115000.00
MED.SW balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 48619000.00
MED.SW income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 7747000.00
MED.SW income_statement (annual, 2023-12-31) — Total Other Finance Cost: 908000.00
MED.SW balance_sheet (annual, 2023-12-31) — Total Tax Payable: 2902000.00
MED.SW balance_sheet (annual, 2023-12-31) — Treasury Stock: 0.00
MED.SW balance_sheet (annual, 2023-12-31) — Work In Process: 15200000.00
MED.SW balance_sheet (annual, 2023-12-31) — Working Capital: 95463000.00
MED.SW income_statement (annual, 2024-12-31) — +Operating Expense: 171456000.00
MED.SW income_statement (annual, 2024-12-31) — +Total Revenue: 224831000.00
MED.SW balance_sheet (annual, 2024-12-31) — Accounts Payable: 8856000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 8856000.00
MED.SW balance_sheet (annual, 2024-12-31) — Accounts Receivable: 41419000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 41419000.00
MED.SW balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -99517000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -99517000.00
MED.SW balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -3491000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -3491000.00
MED.SW cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 3098000.00
MED.SW balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 790000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 790000.00
MED.SW income_statement (annual, 2024-12-31) — Basic Average Shares: 12377721.00
MED.SW income_statement (annual, 2024-12-31) — Basic EPS: 0.29
MED.SW cash_flow (annual, 2024-12-31) — Beginning Cash Position: 25201000.00
MED.SW balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 55772000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 55772000.00
MED.SW cash_flow (annual, 2024-12-31) — Capital Expenditure: -11092000.00
MED.SW balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 7331000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 7331000.00
MED.SW balance_sheet (annual, 2024-12-31) — Capital Stock: 2719000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Capital Stock: 2719000.00
MED.SW balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 138686000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 138686000.00
MED.SW balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 138686000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 138686000.00
MED.SW cash_flow (annual, 2024-12-31) — Change In Inventory: -10847000.00
MED.SW cash_flow (annual, 2024-12-31) — Change In Payable: 3449000.00
MED.SW cash_flow (annual, 2024-12-31) — Change In Receivables: 38000.00
MED.SW cash_flow (annual, 2024-12-31) — Change In Working Capital: -7360000.00
MED.SW cash_flow (annual, 2024-12-31) — Changes In Cash: 113593000.00
MED.SW balance_sheet (annual, 2024-12-31) — Common Stock: 2719000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Common Stock: 2719000.00
MED.SW balance_sheet (annual, 2024-12-31) — Common Stock Equity: 269646000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 269646000.00
MED.SW cash_flow (annual, 2024-12-31) — Common Stock Issuance: 629000.00
MED.SW income_statement (annual, 2024-12-31) — Cost Of Revenue: 46148000.00
MED.SW balance_sheet (annual, 2024-12-31) — Current Assets: 265945000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Current Assets: 265945000.00
MED.SW balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 7331000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 7331000.00
MED.SW balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 7331000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 7331000.00
MED.SW balance_sheet (annual, 2024-12-31) — Current Liabilities: 51018000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 51018000.00
MED.SW balance_sheet (annual, 2024-12-31) — Current Provisions: 2570000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Current Provisions: 2570000.00
MED.SW cash_flow (annual, 2024-12-31) — Deferred Tax: -1029000.00
MED.SW cash_flow (annual, 2024-12-31) — Depreciation: 19202000.00
MED.SW cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 22300000.00
MED.SW income_statement (annual, 2024-12-31) — Diluted Average Shares: 12406024.00
MED.SW income_statement (annual, 2024-12-31) — Diluted EPS: 0.28
MED.SW income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 3528000.00
MED.SW income_statement (annual, 2024-12-31) — EBIT: 7884000.00
MED.SW income_statement (annual, 2024-12-31) — EBITDA: 30184000.00
MED.SW cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -109000.00
MED.SW cash_flow (annual, 2024-12-31) — End Cash Position: 138686000.00
MED.SW cash_flow (annual, 2024-12-31) — Financing Cash Flow: 100583000.00
MED.SW balance_sheet (annual, 2024-12-31) — Finished Goods: 22360000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Finished Goods: 22360000.00
MED.SW cash_flow (annual, 2024-12-31) — Free Cash Flow: 20980000.00
MED.SW cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
MED.SW cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 115000.00
MED.SW income_statement (annual, 2024-12-31) — General And Administrative Expense: 38573000.00
MED.SW balance_sheet (annual, 2024-12-31) — Goodwill: 37622000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Goodwill: 37622000.00
MED.SW balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 51861000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 51861000.00
MED.SW balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 44910000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 44910000.00
MED.SW balance_sheet (annual, 2024-12-31) — Gross PPE: 175469000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Gross PPE: 175469000.00
MED.SW income_statement (annual, 2024-12-31) — Gross Profit: 178683000.00
MED.SW income_statement (annual, 2024-12-31) — Interest Expense: 5385000.00
MED.SW income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 5385000.00
MED.SW income_statement (annual, 2024-12-31) — Interest Income: 1326000.00
MED.SW income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1326000.00
MED.SW cash_flow (annual, 2024-12-31) — Interest Paid Cff: -4618000.00
MED.SW cash_flow (annual, 2024-12-31) — Interest Received Cfo: 1436000.00
MED.SW balance_sheet (annual, 2024-12-31) — Inventory: 79148000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Inventory: 79148000.00
MED.SW balance_sheet (annual, 2024-12-31) — Invested Capital: 269646000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Invested Capital: 269646000.00
MED.SW cash_flow (annual, 2024-12-31) — Investing Cash Flow: -19062000.00
MED.SW balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 790000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 790000.00
MED.SW balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 34379000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 34379000.00
MED.SW cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 629000.00
MED.SW cash_flow (annual, 2024-12-31) — Issuance Of Debt: 112398000.00
MED.SW balance_sheet (annual, 2024-12-31) — Land And Improvements: 0.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 0.00
MED.SW balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 17867000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 17867000.00
MED.SW balance_sheet (annual, 2024-12-31) — Long Term Debt: 95093000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 95093000.00
MED.SW balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 113443000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 113443000.00
MED.SW cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 112398000.00
MED.SW balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 34379000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 34379000.00
MED.SW balance_sheet (annual, 2024-12-31) — Long Term Provisions: 2827000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 2827000.00
MED.SW balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 59972000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 59972000.00
MED.SW cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
MED.SW cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 629000.00
MED.SW income_statement (annual, 2024-12-31) — Net Income: 3528000.00
MED.SW income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 3528000.00
MED.SW income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 3528000.00
MED.SW income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 3528000.00
MED.SW income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 3528000.00
MED.SW cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 3528000.00
MED.SW income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 3528000.00
MED.SW cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -3920000.00
MED.SW income_statement (annual, 2024-12-31) — Net Interest Income: -5477000.00
MED.SW cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 207000.00
MED.SW cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 111473000.00
MED.SW cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 112398000.00
MED.SW income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -5477000.00
MED.SW cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1000.00
MED.SW cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -8513000.00
MED.SW balance_sheet (annual, 2024-12-31) — Net PPE: 75952000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Net PPE: 75952000.00
MED.SW cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -6836000.00
MED.SW cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -925000.00
MED.SW balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 217785000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 217785000.00
MED.SW balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 31036000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 31036000.00
MED.SW balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 4979000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 4979000.00
MED.SW balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 17058000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 17058000.00
MED.SW income_statement (annual, 2024-12-31) — Normalized EBITDA: 30184000.00
MED.SW income_statement (annual, 2024-12-31) — Normalized Income: 3528000.00
MED.SW cash_flow (annual, 2024-12-31) — Operating Cash Flow: 32072000.00
MED.SW income_statement (annual, 2024-12-31) — Operating Income: 7227000.00
MED.SW income_statement (annual, 2024-12-31) — Operating Revenue: 224831000.00
MED.SW balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 12395875.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 12395875.00
MED.SW cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
MED.SW balance_sheet (annual, 2024-12-31) — Other Current Assets: -2000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Other Current Assets: -2000.00
MED.SW balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 8145000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 8145000.00
MED.SW balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 14239000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 14239000.00
MED.SW balance_sheet (annual, 2024-12-31) — Other Inventories: 41599000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Other Inventories: 41599000.00
MED.SW cash_flow (annual, 2024-12-31) — Other Non Cash Items: -855000.00
MED.SW balance_sheet (annual, 2024-12-31) — Other Non Current Assets: -2000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: -2000.00
MED.SW balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 990000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 990000.00
MED.SW balance_sheet (annual, 2024-12-31) — Other Payable: 12742000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Other Payable: 12742000.00
MED.SW balance_sheet (annual, 2024-12-31) — Other Properties: 59725000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Other Properties: 59725000.00
MED.SW balance_sheet (annual, 2024-12-31) — Other Receivables: 4800000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Other Receivables: 4800000.00
MED.SW income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
MED.SW balance_sheet (annual, 2024-12-31) — Payables: 23749000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Payables: 23749000.00
MED.SW balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3953000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3953000.00
MED.SW balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1221000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 1221000.00
MED.SW income_statement (annual, 2024-12-31) — Pretax Income: 2499000.00
MED.SW balance_sheet (annual, 2024-12-31) — Properties: 0.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
MED.SW cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 687000.00
MED.SW cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
MED.SW cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -3920000.00
MED.SW cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
MED.SW cash_flow (annual, 2024-12-31) — Purchase Of PPE: -7172000.00
MED.SW balance_sheet (annual, 2024-12-31) — Raw Materials: 1243000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Raw Materials: 1243000.00
MED.SW income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 46148000.00
MED.SW income_statement (annual, 2024-12-31) — Reconciled Depreciation: 22300000.00
MED.SW cash_flow (annual, 2024-12-31) — Repayment Of Debt: -925000.00
MED.SW income_statement (annual, 2024-12-31) — Research And Development: 43104000.00
MED.SW balance_sheet (annual, 2024-12-31) — Retained Earnings: -19297000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -19297000.00
MED.SW cash_flow (annual, 2024-12-31) — Sale Of Investment: 207000.00
MED.SW cash_flow (annual, 2024-12-31) — Sale Of PPE: 336000.00
MED.SW income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 101932000.00
MED.SW income_statement (annual, 2024-12-31) — Selling General And Administration: 140505000.00
MED.SW balance_sheet (annual, 2024-12-31) — Share Issued: 13595540.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Share Issued: 13595540.00
MED.SW cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
MED.SW cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -925000.00
MED.SW cash_flow (annual, 2024-12-31) — Stock Based Compensation: 966000.00
MED.SW balance_sheet (annual, 2024-12-31) — Stockholders Equity: 269646000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 269646000.00
MED.SW balance_sheet (annual, 2024-12-31) — Tangible Book Value: 217785000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 217785000.00
MED.SW income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MED.SW income_statement (annual, 2024-12-31) — Tax Provision: -1029000.00
MED.SW income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.09
MED.SW balance_sheet (annual, 2024-12-31) — Taxes Receivable: 673000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 673000.00
MED.SW cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -5577000.00
MED.SW balance_sheet (annual, 2024-12-31) — Total Assets: 459961000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Total Assets: 459961000.00
MED.SW balance_sheet (annual, 2024-12-31) — Total Capitalization: 269646000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 269646000.00
MED.SW balance_sheet (annual, 2024-12-31) — Total Debt: 120774000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Total Debt: 120774000.00
MED.SW balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 269646000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 269646000.00
MED.SW income_statement (annual, 2024-12-31) — Total Expenses: 217604000.00
MED.SW balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 190315000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 190315000.00
MED.SW balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 194016000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 194016000.00
MED.SW balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 139297000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 139297000.00
MED.SW income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 7865000.00
MED.SW income_statement (annual, 2024-12-31) — Total Other Finance Cost: 1418000.00
MED.SW balance_sheet (annual, 2024-12-31) — Total Tax Payable: 2151000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 2151000.00
MED.SW balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 1199665.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 1199665.00
MED.SW balance_sheet (annual, 2024-12-31) — Treasury Stock: 240000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 240000.00
MED.SW balance_sheet (annual, 2024-12-31) — Work In Process: 13946000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Work In Process: 13946000.00
MED.SW balance_sheet (annual, 2024-12-31) — Working Capital: 214927000.00
MED.SW balance_sheet (quarterly, 2024-12-31) — Working Capital: 214927000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 8900000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 46098000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2724000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 120509000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 120509000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Common Stock: 2724000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 261207000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Current Assets: 264772000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 8101000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 49893000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Current Provisions: 1816000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 57323000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Gross PPE: 77940000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Inventory: 86855000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Invested Capital: 261207000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 775000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 34938000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 115781000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 34938000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 2861000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Minority Interest: -2000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Net PPE: 77940000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 203884000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 29956000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 5412000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 14000000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 12418362.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 7170000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1166000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Other Payable: 19474000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Other Properties: 77940000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Other Receivables: 7768000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Payables: 29212000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 2729000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -25274000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Share Issued: 13618027.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 261207000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 203884000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 813000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Total Assets: 465703000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 261207000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Total Debt: 123882000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 261205000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 204498000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 200932000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 154605000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 838000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 15385000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 1199665.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 240000.00
MED.SW balance_sheet (quarterly, 2025-06-30) — Working Capital: 214879000.00
MED.SW income_statement (annual, 2025-12-31) — +Operating Expense: 202396000.00
MED.SW income_statement (annual, 2025-12-31) — +Total Revenue: 269257000.00
MED.SW balance_sheet (annual, 2025-12-31) — Accounts Payable: 16089000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 16089000.00
MED.SW balance_sheet (annual, 2025-12-31) — Accounts Receivable: 50337000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 50337000.00
MED.SW balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -109457000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -109457000.00
MED.SW balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2844000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2844000.00
MED.SW cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 4525000.00
MED.SW balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 1279000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 1279000.00
MED.SW income_statement (annual, 2025-12-31) — Basic Average Shares: 12412825.00
MED.SW income_statement (annual, 2025-12-31) — Basic EPS: 0.67
MED.SW cash_flow (annual, 2025-12-31) — Beginning Cash Position: 138686000.00
MED.SW balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 65301000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 65301000.00
MED.SW cash_flow (annual, 2025-12-31) — Capital Expenditure: -25475000.00
MED.SW balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 27533000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 27533000.00
MED.SW balance_sheet (annual, 2025-12-31) — Capital Stock: 2726000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2726000.00
MED.SW balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 32966000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 32966000.00
MED.SW balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 32966000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 32966000.00
MED.SW cash_flow (annual, 2025-12-31) — Change In Inventory: 5718000.00
MED.SW cash_flow (annual, 2025-12-31) — Change In Payable: 6345000.00
MED.SW cash_flow (annual, 2025-12-31) — Change In Receivables: -2474000.00
MED.SW cash_flow (annual, 2025-12-31) — Change In Working Capital: 9589000.00
MED.SW cash_flow (annual, 2025-12-31) — Changes In Cash: -104612000.00
MED.SW balance_sheet (annual, 2025-12-31) — Common Stock: 2726000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Common Stock: 2726000.00
MED.SW balance_sheet (annual, 2025-12-31) — Common Stock Equity: 275872000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 275872000.00
MED.SW cash_flow (annual, 2025-12-31) — Common Stock Issuance: 709000.00
MED.SW income_statement (annual, 2025-12-31) — Cost Of Revenue: 64927000.00
MED.SW balance_sheet (annual, 2025-12-31) — Current Assets: 195282000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Current Assets: 195282000.00
MED.SW balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 8765000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 8765000.00
MED.SW balance_sheet (annual, 2025-12-31) — Current Debt: 17413000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Current Debt: 17413000.00
MED.SW balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 26178000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 26178000.00
MED.SW balance_sheet (annual, 2025-12-31) — Current Liabilities: 88173000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 88173000.00
MED.SW balance_sheet (annual, 2025-12-31) — Current Provisions: 2294000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Current Provisions: 2294000.00
MED.SW cash_flow (annual, 2025-12-31) — Deferred Tax: 3453000.00
MED.SW cash_flow (annual, 2025-12-31) — Depreciation: 20926000.00
MED.SW cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 25451000.00
MED.SW income_statement (annual, 2025-12-31) — Diluted Average Shares: 12446281.00
MED.SW income_statement (annual, 2025-12-31) — Diluted EPS: 0.67
MED.SW income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 8349000.00
MED.SW income_statement (annual, 2025-12-31) — EBIT: 20265000.00
MED.SW income_statement (annual, 2025-12-31) — EBITDA: 45716000.00
MED.SW cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -1108000.00
MED.SW cash_flow (annual, 2025-12-31) — End Cash Position: 32966000.00
MED.SW cash_flow (annual, 2025-12-31) — Financing Cash Flow: 6833000.00
MED.SW balance_sheet (annual, 2025-12-31) — Finished Goods: 34763000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Finished Goods: 34763000.00